Newsletter

×
Treatment solutions for infectious risk waste Linkedin

About us

Based in St. Jean (Toulouse), France, Tesalys is a French manufacturer of equipment for the treatment of infectious waste on site. Toulouse, a global showcase of European industrial know-how, has brought Tesalys the necessary elements for the international development of its STERIPLUSTM technology.

With the STERIPLUSTM crusher-sterilizer, Tesalys has quickly become a leader in bio-contaminated waste treatment systems on the production site.
Tesalys is now present through a network of distributors in more than 90 countries on five continents.

Management team

Three of the founders of Tesalys, Miquel Lozano, Patrick Hengl and Jean-Michel Rodriguez, met for the first time in 1992. Passionate about infection control, waste management and entrepreneurship, it took them a long time to join forces and establish the business.

Associated Partners

Institutional support

TESALYS was supported in its development for the 2014-2017 period by the Occitanie Pyrénées-Méditerranée Region and the FEDER (European Regional Development Fund).

Tesalys benefited from the PassExport and Export Contracts of the Occitania region for carrying out international development actions.

TESALYS also benefited from Innovation and Seed Loans as well as Export Prospecting Insurance, BPIFRANCE devices.

This financial support made it possible to intensify R&D and IP efforts, recruit technical and commercial staff and carry out marketing and communication actions, in particular internationally.

History

1992

Patrick Hengl and Miquel Lozano met for the first time
—–
Exchanges regarding biohazardous waste treatment solutions

1992
2012

Tesalys was set up

STERIPLUS™ 20 was developed

2012
2013

STERIPLUS™ 40 was developed

Tesalys won the Midinvest 2013 award
First sales

2013
2014

Tesalys relocated to new premises in St. Jean (Toulouse)
—–
Round of financing – Equity investment by Entrepreneur Venture

2014
2015

Jury’s prize at the Inn’Ovations 2015 awards
—–
Approval in France by the Ministry of Health and the Ministry of Ecology and Sustainable Development (NF X 30-503)
—–
Sales in around twenty countries

2015
2016

Marco Polo prize
—–
EY’s prize for entrepreneur of the year
—–
STERIPLUSTM 80 was developed
—–
TESALYS continues its development through an external growth operation with the acquisition of Sterishred

2016
2017

Development of sales of the STERISHRED® 250 model

Business growth in South-East Asia

2017
2018

Fundraising (series B) – Entry into the capital of IXO PE and Sigma Gestion
—–
Retirement of one of the founding partners, Patrick Hengl

2018
2019

Investment in a new 1,500 m2 production unit in St. Jean (Toulouse)
—–
“Export Category” winner of the CEO’s Business Challenges Trophy
—–
Delivery of the first units of the STERISHRED® 700 model

2019
2020

Relocation of all production to sites in the Toulouse region.
—–
Tesalys joins French Healthcare

2020

STERIPLUSTM, made in Toulouse, exported to the world

Our solutions are already distributed in Western Europe, Eastern Europe, North Africa, Central Africa, the Middle East, Central Asia, South-east Asia, Central America and South America. Our international distribution network is constantly expanding in order to open up new markets.

With numerous systems already installed globally, Tesalys has taken the initiative and seeks to continue its deployment around the world.